Jeff Yass’s Medovex Corp. Common Stock MDVX Stock Holding History

Jeff Yass’s Portfolio MDVX Stock Details MDVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-15,288	Closed	-$20K	–	10687
2016 Q4	$20K	Buy	+15,288	New	+$22.7K	﹤0.01%	9430
2016 Q2	–	Sell	-15,093	Closed	-$16K	–	9832
2016 Q1	$16K	Buy	+15,093	New	+$18.8K	﹤0.01%	8843

Other funds holding MDVX

MIC

Meridian Investment Counsel Lafayette, California $466M AUM 42.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jeff Yass's MDVX Position: Q1 2017 in Review

Jeff Yass sold out of Medovex Corp. Common Stock (MDVX) in Q1 2017, closing a stake of 15,288 shares — an estimated $20K sold.

Jeff Yass first reported a position in MDVX in Q1 2016 and held it in 2 quarters. The position peaked at $20K in Q4 2016. 6 funds tracked by Wall St. Rank hold MDVX as of Q1 2017.

Jeff Yass reported no remaining Medovex Corp. Common Stock position as of Q1 2017 after selling out during the quarter.
Jeff Yass sold 15,288 Medovex Corp. Common Stock shares in Q1 2017, an estimated $20K.
Jeff Yass first reported a position in Medovex Corp. Common Stock in Q1 2016 and held it in 2 quarters.
Jeff Yass's Medovex Corp. Common Stock position peaked at $20K in Q4 2016.
6 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.